[1]BioorganicandMedicinalChemistryLetters,2014,vol.24,#24,p.5576-5580
[1]RSCAdvances,2015,vol.5,#39,p.31226-31230
[1]JournaloftheAmericanChemicalSociety,1935,vol.57,p.1068
[2]JournalfuerPraktischeChemie(Leipzig),1893,vol.<2>47,p.303
[1]Synlett,2010,#1,p.101-106
[1]ACSMedicinalChemistryLetters,2016,vol.7,#5,p.502-507
[1]JournalofHeterocyclicChemistry,1972,vol.9,p.1449
[1]Patent:DE680661,1937,
[1]JournaloftheAmericanChemicalSociety,1935,vol.57,p.1068
[2]JournalfurpraktischeChemie(Leipzig1954),1893,vol.<2>47,p.303
[1]ChemischeBerichte,1956,vol.89,p.224,234
[1]JournalofMedicinalChemistry,1990,vol.33,p.434-444
[2]Patent:DE737931,1940, DRP/DRBPOrg.Chem.,
Title: Stimulation of host immune defenses by a small molecule protects C. elegans from bacterial infection.
Journal: PLoS genetics 20120601
Title: Discovery and optimization of 2,4-diaminoquinazoline derivatives as a new class of potent dengue virus inhibitors.
Journal: Journal of medicinal chemistry 20120412
Title: Synthesis of 2,4-diaminoquinazolines and tricyclic quinazolines by cascade reductive cyclization of methyl N-cyano-2-nitrobenzimidates.
Journal: The Journal of organic chemistry 20120316
Title: Design, synthesis, and biological evaluation of new diaminoquinazolines as β-catenin/Tcf4 pathway inhibitors.
Journal: Journal of medicinal chemistry 20120209
Title: Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.
Journal: Bioorganic & medicinal chemistry letters 20110915
Title: New insights into the structural requirements for pro-apoptotic agents based on 2,4-diaminoquinazoline, 2,4-diaminopyrido[2,3-d]pyrimidine and 2,4-diaminopyrimidine derivatives.
Journal: European journal of medicinal chemistry 20110901
Title: Importazole, a small molecule inhibitor of the transport receptor importin-β.
Journal: ACS chemical biology 20110715
Title: The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.
Journal: Disease models & mechanisms 20110701
Title: Synthesis and biological evaluation of 2,4-diaminoquinazoline derivatives as novel heat shock protein 90 inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20110315
Title: Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design.
Journal: Journal of tropical medicine 20110101
Title: Utility of survival motor neuron ELISA for spinal muscular atrophy clinical and preclinical analyses.
Journal: PloS one 20110101
Title: Spinal muscular atrophy.
Journal: Orphanet journal of rare diseases 20110101
Title: Synthesis of highly functionalized 2,4-diaminoquinazolines as anticancer and anti-HIV agents.
Journal: Bioorganic & medicinal chemistry letters 20100801
Title: Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.
Journal: Bioorganic & medicinal chemistry 20100601
Title: Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy.
Journal: Human molecular genetics 20100201
Title: Development and validation of a cytochrome c-coupled assay for pteridine reductase 1 and dihydrofolate reductase.
Journal: Analytical biochemistry 20100115
Title: Binding modes of 2,4-diaminoquinazoline and 2,4-diaminopteridine analogs to P. falciparum dihydrofolate reductase enzyme: Molecular docking studies.
Journal: Indian journal of pharmaceutical sciences 20100101
Title: Mouse survival motor neuron alleles that mimic SMN2 splicing and are inducible rescue embryonic lethality early in development but not late.
Journal: PloS one 20100101
Title: N-(3,4-dimethoxyphenethyl)-4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2[1H]-yl)-6,7-dimethoxyquinazolin-2-amine (CP-100,356) as a 'chemical knock-out equivalent' to assess the impact of efflux transporters on oral drug absorption in the rat.
Journal: Journal of pharmaceutical sciences 20091201
Title: 2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer.
Journal: Bioorganic & medicinal chemistry letters 20090901
Title: N9-substituted 2,4-diaminoquinazolines: synthesis and biological evaluation of lipophilic inhibitors of pneumocystis carinii and toxoplasma gondii dihydrofolate reductase.
Journal: Journal of medicinal chemistry 20081009
Title: Potent CCR4 antagonists: synthesis, evaluation, and docking study of 2,4-diaminoquinazolines.
Journal: Bioorganic & medicinal chemistry 20080901
Title: Discovery of potent CCR4 antagonists: Synthesis and structure-activity relationship study of 2,4-diaminoquinazolines.
Journal: Bioorganic & medicinal chemistry 20080715
Title: Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
Journal: Journal of medicinal chemistry 20080214
Title: Binding of an aminoacridine derivative to a GAAA RNA tetraloop.
Journal: Bioorganic & medicinal chemistry letters 20041206
Title: A novel method of synthesis of 2,4-diamino-6-arylmethylquinazolines using palladium(0)-catalyzed organozinc chemistry.
Journal: The Journal of organic chemistry 20011102
Title: Traceless solid-phase synthesis of 2,4-diaminoquinazolines.
Journal: Organic letters 20010222
Title: Solid-phase synthesis of 2,4-diaminoquinazoline libraries.
Journal: Journal of combinatorial chemistry 20010101
Title: Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
Journal: Biochemistry 19981006
Title: Selective inhibitors of Candida albicans dihydrofolate reductase: activity and selectivity of 5-(arylthio)-2,4-diaminoquinazolines.
Journal: Journal of medicinal chemistry 19950901
Title: 2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.
Journal: Journal of medicinal chemistry 19950303
Title: Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytes.
Journal: Antimicrobial agents and chemotherapy 19940901